Delivery Order SPE2DE24DA012-SPE2D625F4ELS

Johnson & Johnson Health Care Systems Inc. (Jjhcs) was awarded a $12,519.52 fixed-price delivery order on September 25, 2025, for an Attune Femoral Porous Cruciate Retaining Size 7 medical device. The contract, issued without a set-aside designation, is funded by the Defense Department's Medical Supply Chain office and will be performed at the company's facility in Raritan, New Jersey, with an ultimate completion date of September 30, 2025. This delivery order falls under Jjhcs's broader $86.1 million Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, which runs through July 2029 and covers a comprehensive range of medical supplies, particularly DePuy Synthes joint procedural packages and orthopedic implants.

As a large business prime contractor, Jjhcs specializes in providing advanced surgical products and orthopedic devices to federal healthcare systems, particularly the Department of Defense and Veterans Affairs. The Attune Femoral component being delivered under this order represents the type of sophisticated joint replacement implant technology that Jjhcs routinely supplies through the DLA Troop Support Medical Electronic Catalog (ECAT) system to support military medical facilities. Individual delivery orders under the primary IDC typically range from under $5,000 to over $95,000, with Jjhcs providing both equipment and on-site technical support to federal hospitals.